Human Stem Cells Institute Stock
Stocks
ISKJ
RU000A0JNAB6
Healthcare Facilities & Services
OTC Markets Traded|
End-of-day quote
Moscow Micex - RTS
2022-07-08
|
5-day change | 1st Jan Change | ||
| 59.54 RUB | +1.43% |
|
-.--% | - |
| 04-27 | Artgen Biotech PJSC Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
| 25-08-29 | Artgen Biotech PJSC Reports Earnings Results for the Half Year Ended June 30, 2025 | CI |
| Market Cap | 4.4B 53.18M 45.51M 42.56M 38.95M 73.23M 5.09B 74.09M 503M 196M 2.55B 200M 195M 8.45B | P/E 2024 |
25.7x | P/E 2025 | 46.2x |
|---|---|---|---|---|---|
| Enterprise Value | 4.64B 56.01M 47.94M 44.83M 41.02M 77.13M 5.36B 78.04M 530M 207M 2.69B 210M 206M 8.9B | EV / Sales 2024 |
3.02x | EV / Sales 2025 | 2.7x |
| Free-Float |
17.07% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | +1.43% |
| 5 years | 52.52 |  | 177 |
| 10 years | 7.6 | | 177 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | - | |
Galina Bulanova
DFI | Director of Finance/CFO | - | - |
Dmitry Krasotkin
CIO | Chief Investment Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Andrey Isaev
BRD | Director/Board Member | 55 | 2007-06-27 |
Sergey Kiselev
BRD | Director/Board Member | 68 | 2010-08-22 |
Roman Deev
BRD | Director/Board Member | 47 | 2014-01-08 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.43% | -.--% | -.--% | -.--% | 54.74M | |
| -0.67% | -2.07% | +31.35% | +39.23% | 120B | |
| +5.64% | +4.24% | +4.63% | +59.53% | 87.96B | |
| +1.28% | +3.54% | +32.53% | +83.06% | 26.63B | |
| -0.25% | +4.12% | -3.88% | -9.17% | 22.17B | |
| +3.00% | +5.14% | +54.32% | +297.24% | 21.95B | |
| +1.48% | +1.75% | -8.03% | +14.24% | 14.2B | |
| -1.83% | -2.07% | -7.32% | -9.94% | 12.66B | |
| -0.81% | -2.99% | +26.49% | +71.15% | 11.18B | |
| -1.74% | +8.46% | +127.42% | +2,036.36% | 9.88B | |
| Average | +0.75% | -0.04% | +25.75% | +258.17% | 32.64B | |
| Weighted average by Cap. | +1.48% | -0.64% | +22.92% | +120.88% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 1.52B 18.38M 15.73M 14.71M 13.46M 25.31M 1.76B 25.61M 174M 67.79M 883M 68.99M 67.51M 2.92B | 1.72B 20.74M 17.75M 16.6M 15.19M 28.55M 1.98B 28.89M 196M 76.46M 996M 77.82M 76.15M 3.29B |
| Net income | 215M 2.6M 2.22M 2.08M 1.9M 3.58M 248M 3.62M 24.57M 9.58M 125M 9.74M 9.54M 412M | 96.95M 1.17M 1M 938K 858K 1.61M 112M 1.63M 11.08M 4.32M 56.28M 4.4M 4.3M 186M |
| Net Debt | 199M 2.41M 2.06M 1.93M 1.76M 3.31M 230M 3.35M 22.77M 8.88M 116M 9.03M 8.84M 382M | 234M 2.83M 2.42M 2.27M 2.08M 3.9M 271M 3.95M 26.81M 10.45M 136M 10.63M 10.41M 450M |
Employees
-
- Stock Market
- Stocks
- ISKJ Stock
Select your edition
All financial news and data tailored to specific country editions
